Patent details
EP2604257 Title: Oral transmucosal dosage forms comprising sufentanil and triazolam
Basic Information
- Publication number:
- EP2604257
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP131587818
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Oral transmucosal dosage forms comprising sufentanil and triazolam
- French Title of Invention:
- Formes posologiques transmucosales orales comprenant du sufentanil et du triazolam
- German Title of Invention:
- Orale transmukosale Dosierungsformen mit Sufentanil und Triazolam
- SPC Number:
Dates
- Filing date:
- 07/08/2008
- Grant date:
- 28/06/2017
- EP Publication Date:
- 19/06/2013
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 28/06/2017
- EP B1 Publication Date:
- 28/06/2017
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 07/08/2017
- Expiration date:
- 07/08/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 28/06/2017
- Name:
- Acelrx Pharmaceuticals, Inc.
- Address:
- 575 Chesapeake Drive, Redwood City, CA 94063, United States (US)
Inventor
1
- Name:
- Palmer, Pamela
- Address:
- United States (US)
2
- Name:
- Tzannis, Stelios
- Address:
- United States (US)
3
- Name:
- Schreck, Thomas
- Address:
- United States (US)
Priority
- Priority Number:
- 954501 P
- Priority Date:
- 07/08/2007
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 9/00; A61K 9/70; A61K 31/4535; A61K 31/5517; A61P 25/20;
Publication
European Patent Bulletin
1
- Issue number:
- 201726
- Publication date:
- 28/06/2017
- Description:
- Grant (B1)
2
- Issue number:
- 201731
- Publication date:
- 02/08/2017
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 31/12/2017 | Outgoing Correspondence | 1 |